Researchers demonstrate how CRISPR / Cas9 - mediated exon skipping, or myoediting, may rescue
dystrophin function in a majority of Duchenne muscular dystrophy patients
Not exact matches
«Our work suggests that AMPK signaling may be one of the links between the loss of
dystrophin and the impaired nNOS
function that is seen in muscular dystrophy,» says Michele, senior study author and professor of molecular & integrative physiology and internal medicine at the University of Michigan.
Experiments have shown treatment with sildenafil significantly improved heart
function in mice missing the
dystrophin protein.
«AMPK normally helps to turn on nNOS
function in muscle cells, for instance when we exercise, and when
dystrophin is lost, AMPK does not turn on appropriately.»
These splice sites instruct the genetic machinery to build abnormal
dystrophin molecules, but once the gene is successfully edited it expresses a much - improved
dystrophin protein product, enhancing the
function of the muscle tissue.
12 guide RNAs developed to find mutation «hotspots» along the
dystrophin gene helped rescue cardiac
function to near - normal levels in human heart muscle tissue.
Moreover, large - scale screens in the C. elegans DMD model allowed identifying genetic and pharmacologic suppressors of
dystrophin - dependent muscle degeneration; some of them positively impact mitochondrial
functions or structure under stress conditions, or are involved in signaling pathways linked to mitochondria, and others are associated to proteostasis pathways such as autophagy, proteasome and Unfolded Protein Response (UPR).
Campbell and his colleagues began their work by genetically engineering knockout mice that lacked a
functioning protein called δ - sarcoglycan, which is part of a larger molecular assemblage called the
dystrophin - glycoprotein complex (DGC).
DMD is caused by the absence of a protein called
dystrophin which is essential in maintaining the healthy
function of muscles in the body.
«This evidence supports our concept of «tipping point» where the number and extent of fiber branching reaches a level where the branching itself terminally compromises muscle
function, irrespective of the absence of
dystrophin,» the researchers wrote.
«Our work suggests that AMPK signaling may be one of the links between the loss of
dystrophin and the impaired nNOS
function that is seen in muscular dystrophy,» says Michele, senior study author and associate professor of molecular & integrative physiology and internal medicine at the University of Michigan.
The technique partially restored not only functional
dystrophin expression, but also dystrophic muscle
function.
Muscular dystrophy in dogs is caused by an inherited mutated
dystrophin gene that disrupts the
dystrophin protein production, resulting in loss of muscle
function.